Barbara A. Carlin, CPA
Barb Carlin is a finance professional with over 15 years of experience in leadership roles, predominantly within the emerging growth life sciences industry. Working within small to mid-sized pharmaceutical companies during periods of high-growth, Barb has a passion for building and leading teams, establishing infrastructure, collaborating with international management teams in both pre-commercial and commercial environments.
Barb currently serves as the Vice President of Finance & Administration for Egalet Corporation (NASDAQ: EGLT), a specialty pharmaceutical company developing and planning to commercialize proprietary, abuse-deterrent oral products for the treatment of pain and in other indications. In her role at Egalet, Barb is responsible for the financial oversight of the US and Danish subsidiaries, internal and external financial reporting and Sarbanes Oxley.
Prior to Egalet, Barb served as Finance Director of Sobi, Inc, the US subsidiary of Swedish Orphan Biovitrum AB (STO: SOBI), an international biopharmaceutical company focusing on rare diseases. Barb played an integral role in creating the financial infrastructure for the newly formed US entity.
Barb also held positions of leadership in both private and public settings, including Director of Corporate Project Management at Topaz Pharmaceuticals, Vice President of Finance at Genaera Corporation, Accounting Manager at Vicuron Pharmaceuticals, Inc. and Director of Accounting at Taylor & Francis. She began her career as an auditor with Deloitte & Touche LLP.
Barb earned her B.S. degree in Accounting from St. Joseph’s University in Philadelphia, PA and is a Certified Public Accountant, licensed in Pennsylvania.